Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Rat (Rattus) RIPK1 Antibodies:
anti-Human RIPK1 Antibodies:
anti-Mouse (Murine) RIPK1 Antibodies:
Go to our pre-filtered search.
Chicken Monoclonal RIPK1 Primary Antibody for IF, IP - ABIN967985
Takahashi, Tanaka, Brannan, Jenkins, Copeland, Suda, Nagata: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. in Cell 1994
Show all 5 Pubmed References
Chicken Monoclonal RIPK1 Primary Antibody for IF, IP - ABIN967984
Devin, Lin, Yamaoka, Li, Karin, Liu Zg: The alpha and beta subunits of IkappaB kinase (IKK) mediate TRAF2-dependent IKK recruitment to tumor necrosis factor (TNF) receptor 1 in response to TNF. in Molecular and cellular biology 2001
Show all 5 Pubmed References
Human Polyclonal RIPK1 Primary Antibody for ELISA, ICC - ABIN4350584
Nilsson, Loganathan, Sekiguchi, Matsuba, Hui, Tsubuki, Tanaka, Iwata, Saito, Saido: Aβ secretion and plaque formation depend on autophagy. in Cell reports 2013
Show all 3 Pubmed References
Human Polyclonal RIPK1 Primary Antibody for IF (p), IHC (p) - ABIN715016
Luo, Roy, Xiao, Sun, Liang, Chen, Fu, Sun, Zhu, Ye, Liu: Lycorine induces programmed necrosis in the multiple myeloma cell line ARH-77. in Tumour biology 2014
Show all 2 Pubmed References
Human Monoclonal RIPK1 Primary Antibody for IP, WB - ABIN967307
Stanger, Leder, Lee, Kim, Seed: RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. in Cell 1995
Human Polyclonal RIPK1 Primary Antibody for IHC, IHC (p) - ABIN4350581
Ratovitski: Phospho-ΔNp63α-responsive microRNAs contribute to the regulation of necroptosis in squamous cell carcinoma upon cisplatin exposure. in FEBS letters 2015
Human Polyclonal RIPK1 Primary Antibody for ICC, IF - ABIN4350585
Hirsch, von der Wall, Hummel, Dürkop: RIP1 expression is necessary for CD30-mediated cell death induction in anaplastic large-cell lymphoma cells. in Laboratory investigation; a journal of technical methods and pathology 2013
the cytoplasmic retinoic acid receptor gamma (show RARG Antibodies) (RARgamma) controls receptor-interacting protein kinase (show CDK7 Antibodies) 1 (RIP1 (show UQCRFS1 Antibodies))-initiated cell death when cellular inhibitor of apoptosis (cIAP) activity is blocked.
SIRT2 (show SIRT2 Antibodies) and RIPK1 were localized to the syncytiotrophoblast, villous leukocytes and vasculature in all preterm placentas. A significant reduction in SIRT2 (show SIRT2 Antibodies) protein expression in both preeclampsia and fetal growth restricted placentas was identified. RIPK1 mRNA expression was significantly increased in preeclampsia placentas. Immunofluorescence identified both SIRT2 (show SIRT2 Antibodies) and RIPK1 in the cytotrophoblast cytoplasm.
RIPK1 inhibits the transcriptional activity of VDR.
Results show that downregulation of RIP1 (show UQCRFS1 Antibodies) results in increased resistance to SN38, implying a requirement for RIP1 (show UQCRFS1 Antibodies) in mediating cytotoxicity through the TNF (show TNF Antibodies)/TNFR (show TNFRSF1A Antibodies) signaling pathway.
Renal clear cell carcinoma cells cells express increased amounts of RIPK1 and RIPK3 (show RIPK3 Antibodies) and are poised to undergo necroptosis in response to TNFR1 (show TNFRSF1A Antibodies) signaling.
Data suggest that pro-death signals through TIR-domain-containing adapter-inducing interferon-beta (show IFNB1 Antibodies) (TRIF (show TRIM69 Antibodies)) are regulated by autophagy and propose that pro-apoptotic signalling through TRIF (show TRIM69 Antibodies)/RIPK1/caspase-8 (show CASP8 Antibodies) occurs in fibrillary platforms.
UL45 promoted the UL48-RIP1 (show UQCRFS1 Antibodies) interaction and re-localization of RIP1 (show UQCRFS1 Antibodies) to the UL48-containing virion assembly complex.
we provide evidence that p62 (show GTF2H1 Antibodies) is implicated in the activation of NF-kappaB (show NFKB1 Antibodies) signaling that is partly dependent on RIP1 (show UQCRFS1 Antibodies)
inactivation of RIP1 (show UQCRFS1 Antibodies)/RIP3 (show RIPK3 Antibodies) resulted in reduction of SOCS1 (show SOCS1 Antibodies) protein levels and partial differentiation of AML (show RUNX1 Antibodies) cells. AML (show RUNX1 Antibodies) cells with inactivated RIP1 (show UQCRFS1 Antibodies)/RIP3 (show RIPK3 Antibodies) signaling show increased sensitivity to IFN-gamma-induced (show SAMHD1 Antibodies) differentiation.
Data show that pan (show SUPT6H Antibodies)-caspase (show CASP3 Antibodies) inhibitors facilitated 5-fluorouracil (5-FU)-induced necroptosis mediated by secretion of tumor necrosis factor alpha (TNF-alpha (show TNF Antibodies)) driven by nuclear factor kappaB (NF-kappaB (show NFKB1 Antibodies)) and required RIP1 (show UQCRFS1 Antibodies) kinase.
TNFalpha (show TNF Antibodies)-induced phosphorylation of RIPK1 in the intermediate domain by TAK1 (show NR2C2 Antibodies) plays a key role in regulating the decision between three distinct mechanisms of cell death: necroptosis, RIPK1-independent and dependent apoptosis.
K45 mediated kinase activity of RIPK1 is not only important for necroptosis but it also has a key role in promoting cytokine signaling and host response to inflammatory stimuli.
Data show that the kinase activity of receptor-interacting protein kinase (show CDK7 Antibodies) 1 (RIPK1) is required for Yersinia-induced apoptosis.
p38MAPK (show MAPK14 Antibodies)/MK2 (show KCNA2 Antibodies) phosphorylation of RIPK1 is a crucial checkpoint for cell fate in inflammation and infection that determines the outcome of bacteria-host cell interaction.
MK2 (show KCNA2 Antibodies)-mediated RIPK1 phosphorylation is an important molecular mechanism limiting the sensitivity of the cells to the cytotoxic effects of TNF (show TNF Antibodies).
An alternative function for RIPK1/RIPK3 (show RIPK3 Antibodies) in vascular permeability.
these results revealed a novel, kinase-independent function of RIP1, which is essential for not only promoting TCR-induced proliferative responses but also in blocking apoptosis in mature T cells.
Data show that the kinase domain of RIPK1 is a disease driver of intracerebral hemorrhage, mediating both acute cell death and functional outcome.
MK2 (show KCNA2 Antibodies)-mediated phosphorylation of RIPK1 serves as a checkpoint within the TNF (show TNF Antibodies) signaling pathway that integrates cell survival and cytokine production.
study identifies a novel role for RIPK1 and RIPK3 (show RIPK3 Antibodies), a pair of homologous serine/threonine kinases previously implicated in the regulation of necroptosis and pathologic tissue injury, in directing IFN-beta (show IFNB1 Antibodies) production in macrophagesges.
Serine-threonine kinase which transduces inflammatory and cell-death signals (necroptosis) following death receptors ligation, activation of pathogen recognition receptors (PRRs), and DNA damage. Upon activation of TNFR1 by the TNF-alpha family cytokines, TRADD and TRAF2 are recruited to the receptor. Ubiquitination by TRAF2 via 'Lys-63'-link chains acts as a critical enhancer of communication with downstream signal transducers in the mitogen-activated protein kinase pathway and the NF-kappa-B pathway, which in turn mediate downstream events including the activation of genes encoding inflammatory molecules. Polyubiquitinated protein binds to IKBKG/NEMO, the regulatory subunit of the IKK complex, a critical event for NF-kappa-B activation. Interaction with other cellular RHIM-containing adapters initiates gene activation and cell death. RIPK1 and RIPK3 association, in particular, forms a necroptosis-inducing complex.
receptor (TNFRSF)-interacting serine-threonine kinase 1
, 1,3,4,5,6-pentakisphosphate 2-kinase
, inositol polyphosphate kinase 1
, inositol-1,3,4,5,6-pentakisphosphate 2-kinase
, inositol-pentakisphosphate 2-kinase
, ins(1,3,4,5,6)P5 2-kinase
, insP5 2-kinase
, cell death protein RIP
, receptor interacting protein
, receptor-interacting protein 1
, receptor-interacting serine/threonine-protein kinase 1
, serine/threonine-protein kinase RIP
, RPA interacting protein delta 2
, RPA interacting protein epsilon
, RPA-interacting protein